ATE206456T1 - Impstoff gegen krankheitserreger, zusammensetzung zur behandlung und vorbeugung von hiv infektionen - Google Patents

Impstoff gegen krankheitserreger, zusammensetzung zur behandlung und vorbeugung von hiv infektionen

Info

Publication number
ATE206456T1
ATE206456T1 AT96924033T AT96924033T ATE206456T1 AT E206456 T1 ATE206456 T1 AT E206456T1 AT 96924033 T AT96924033 T AT 96924033T AT 96924033 T AT96924033 T AT 96924033T AT E206456 T1 ATE206456 T1 AT E206456T1
Authority
AT
Austria
Prior art keywords
pct
composition
hiv infections
prevention
treatment
Prior art date
Application number
AT96924033T
Other languages
English (en)
Inventor
Jean-Claude Chermann
Contel Carole Le
Pascale Galea
Original Assignee
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med filed Critical Inst Nat Sante Rech Med
Application granted granted Critical
Publication of ATE206456T1 publication Critical patent/ATE206456T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT96924033T 1995-06-30 1996-06-28 Impstoff gegen krankheitserreger, zusammensetzung zur behandlung und vorbeugung von hiv infektionen ATE206456T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9507914A FR2735984B1 (fr) 1995-06-30 1995-06-30 Vaccin contre des agents infectieux ayant une phase intracellulaire, composition pour le traitement et la prevention des infections a hiv, anticorps et procede de diagnostic
PCT/FR1996/001006 WO1997002344A2 (fr) 1995-06-30 1996-06-28 Vaccin contre des agents infectieux, composition pour le traitement et la prevention des infections a hiv

Publications (1)

Publication Number Publication Date
ATE206456T1 true ATE206456T1 (de) 2001-10-15

Family

ID=9480577

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96924033T ATE206456T1 (de) 1995-06-30 1996-06-28 Impstoff gegen krankheitserreger, zusammensetzung zur behandlung und vorbeugung von hiv infektionen

Country Status (13)

Country Link
US (1) US6113902A (de)
EP (1) EP0835309B1 (de)
JP (1) JP4036895B2 (de)
CN (1) CN1117148C (de)
AT (1) ATE206456T1 (de)
AU (1) AU6462396A (de)
CA (1) CA2223825A1 (de)
DE (1) DE69615685T2 (de)
DK (1) DK0835309T3 (de)
ES (1) ES2165510T3 (de)
FR (1) FR2735984B1 (de)
PT (1) PT835309E (de)
WO (1) WO1997002344A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2235420A1 (en) 1998-06-17 1999-12-17 Paolo Renzi Antisense oligonucleotides for treating or preventing atopic diseases and neoplastic cell proliferation
FR2836146B1 (fr) * 2002-02-15 2005-01-07 Urrma R & D IMMUNOGLOBULINE IgG3 MARQUEUR DE PROTECTION CONTRE LES MALADIES VIRALES INFECTIEUSES ET SES UTILISATIONS
CN1745094A (zh) * 2002-12-06 2006-03-08 新加坡综合医院有限公司 肽,其抗体,以及它们在中枢神经系统损伤的治疗中的用途
TW200846363A (en) * 2007-03-22 2008-12-01 Urrma R & B Novel human anti-R7V antibodies and uses thereof
EP2374470A1 (de) * 2010-04-08 2011-10-12 Beta Innov Therapeutische Anwendung von Protein Beta-2-M
US20190201496A1 (en) * 2016-09-16 2019-07-04 The Brigham And Women's Hospital, Inc. Blockade of alphafetoprotein (afp) interactions with beta2-microglobulin associated molecules

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK160944C (da) * 1986-01-16 1991-10-21 Novo Industri As Modificerede beta2-mikroglobuliner og farmaceutiske praeparater indeholdende disse
US5733550A (en) * 1990-05-10 1998-03-31 Dana-Farber Cancer Institute, Inc. Method for enhancing the association of exogenous peptides with class I MHC molecules on the surface of antigen presenting cells with β-microglobulin
FR2675508A1 (fr) * 1991-04-18 1992-10-23 Tm Innovation Compose comprenant une sequence peptidique neutralisant l'infection par le cytomegalovirus humain (hcmv) et composition le comportant.
GB9201023D0 (en) * 1992-01-17 1992-03-11 Medical Res Council Vaccines
GB9214871D0 (en) * 1992-07-13 1992-08-26 Medical Res Council Vaccines
US6696061B1 (en) * 1992-08-11 2004-02-24 President And Fellows Of Harvard College Immunomodulatory peptides
GB9307371D0 (en) * 1993-04-08 1993-06-02 Walls Alan J Fusion proteins

Also Published As

Publication number Publication date
DE69615685D1 (de) 2001-11-08
ES2165510T3 (es) 2002-03-16
FR2735984B1 (fr) 1997-09-19
CN1117148C (zh) 2003-08-06
US6113902A (en) 2000-09-05
FR2735984A1 (fr) 1997-01-03
JPH11509407A (ja) 1999-08-24
EP0835309A2 (de) 1998-04-15
AU6462396A (en) 1997-02-05
CN1193349A (zh) 1998-09-16
CA2223825A1 (fr) 1997-01-23
EP0835309B1 (de) 2001-10-04
WO1997002344A3 (fr) 1997-03-06
DE69615685T2 (de) 2002-08-08
WO1997002344A2 (fr) 1997-01-23
JP4036895B2 (ja) 2008-01-23
PT835309E (pt) 2002-03-28
DK0835309T3 (da) 2002-12-02

Similar Documents

Publication Publication Date Title
DE60119734D1 (de) Hpv-e7 zur behandlung von menschlichem papillomavirus
ATE140388T1 (de) Zusammensetzungen enthaltend omega conotoxin peptide derivate und deren verwendung zur behandlung von ischämie-artigen neuronalen schädigungen
BR9502707A (pt) Composto composição farmacêutica e método para o tratamento de uma afecção
DE69637642D1 (de) Und kombinierte zusammensetzungen und deren verwendung
ATE211927T1 (de) Verfahren zur virusinaktivierung in gegenwart eines polyethers und eines agens
ATE166230T1 (de) Verwendung von anti-icam antikörpern zur herstellung eines präparats für die behandlung von endotoxinschock
ATE179614T1 (de) Herpes simplex virus vp16 impfstoffe
MX9101958A (es) Inhibidores de acat de urea de aminosulfonilo
DE60237447D1 (de) Verwendung von polyklonalen anti-hiv ziegenseren als therapeutisches mittel
DE69615685D1 (de) Impstoff gegen krankheitserreger, zusammensetzung zur behandlung und vorbeugung von hiv infektionen
DE60231475D1 (de) Materialien und methoden zur behandlung von hepatitis c
DE60026883D1 (de) Methoden und zusammensetzungen zur behandlung von schmerzen
DK1189627T3 (da) Sammensætninger indeholdende opløselige former af HLA-G til behandling af inflammatoriske patologiske tilstande i huden
GR3034155T3 (en) Water-soluble epipodophyllotoxin derivatives, preparation method therefor, and use thereof as a drug and for treating cancer
SE9400524D0 (sv) Energipreparat
WO2000063386A3 (en) Prevention, diagnosis and treatment of lyme disease
BG102404A (en) The application of flupirtin for the prevention and treatment of diseases related to impairement of the haematopoeic cellular system
DE60013326D1 (de) Verbindungen und verfahren zur behandlung von schmerz
DE69010523D1 (de) Kit oder Zusammensetzung zur Vorbeugung oder Behandlung von HIV-1 Infektionen.
ATE401349T1 (de) Monoklonale antikörper gegen das map-protein und verfahren zu dessen anwendung bei der behandlung bzw. prävention von infektionen
RU2001106308A (ru) Способ лечения гнойных инфекций
EP1419784A3 (de) Proteasom-Impfstoffzusammensetzungen gegen Allergie, Krebs und Toxine

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee